Kanagawa, Japan

Seiya Yamayoshi

This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: The University of Tokyo, Wisconsin Alumni Research Foundation. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seiya Yamayoshi. Retrieved from https://idiyas.com/inventor/seiya-yamayoshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Seiya Yamayoshi: Innovator in Influenza Virus Research

Introduction

Seiya Yamayoshi is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of virology, particularly in the development of influenza vaccines. With a total of 2 patents, his work focuses on enhancing vaccine production efficiency.

Latest Patents

Yamayoshi's latest patents include innovative recombinant influenza viruses with stabilized neuraminidases (NA). These modified influenza virus neuraminidases feature stabilized NA tetramers, which may improve vaccine production efficiency. This advancement is crucial for increasing the yield of vaccine viruses, thereby enhancing public health responses to influenza outbreaks.

Career Highlights

Throughout his career, Seiya Yamayoshi has worked with esteemed organizations such as the Wisconsin Alumni Research Foundation and the University of Tokyo. His research has been pivotal in advancing our understanding of influenza viruses and improving vaccine technologies.

Collaborations

Yamayoshi has collaborated with notable scientists in the field, including Yoshihiro Kawaoka and Yuri Furusawa. These partnerships have fostered innovative research and development in influenza virus studies.

Conclusion

Seiya Yamayoshi's contributions to influenza virus research and vaccine production are invaluable. His innovative patents and collaborations continue to shape the future of virology and public health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…